Maternal serum screening tests are blood tests done during pregnancy. They check for certain substances in your blood to see if you might have a higher risk of certain health problems for you or your baby.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Maternal serum screening uses a blood sample from the pregnant person to estimate whether the fetus is more likely than average to have certain conditions. The best-known versions measure substances made by the fetus and placenta, such as alpha-fetoprotein (AFP), a protein made mainly by the baby's liver, and human chorionic gonadotropin (hCG), a pregnancy hormone from the placenta. The triple screen measures three of these markers in the second trimester; the quad screen adds a fourth, inhibin A, and is slightly more accurate. The tests look mainly for Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) and neural tube defects, which are problems with how the brain and spine form, such as spina bifida. A first-trimester version pairs a blood test with an ultrasound measurement of the back of the baby's neck, and results from both trimesters can be combined for a more accurate estimate. Cell-free DNA screening, which analyzes fragments of genetic material (DNA) from the placenta circulating in the pregnant person's blood, is a related option that can start at 10 weeks. Screening is offered to everyone who is pregnant, not only those at higher risk, although age 35 or older, diabetes treated with insulin and a family history of birth defects raise the baseline chance. Having the test is a personal choice. Some people want the information to prepare or make decisions, and others prefer to decline screening, follow-up testing or both.
Timing matters because the markers change week by week during pregnancy. First-trimester screening is usually done between 10 and 13 weeks. The quad screen is done between 15 and 22 weeks and is most accurate between 16 and 18 weeks; a test of AFP alone is usually done between 15 and 20 weeks. No special preparation is needed, and you can eat and drink normally beforehand. Because the lab interprets the results using your age, weight, background and how far along the pregnancy is, an accurate due date matters, as does telling the care team if you have diabetes or are carrying more than one baby. It helps to think beforehand about how you would use a higher-risk result, since that shapes whether follow-up testing would be useful to you.
The test is an ordinary blood draw. A health professional places a small needle in a vein in your arm and collects a tube of blood, usually within a few minutes. You may feel a brief sting as the needle goes in and some throbbing afterward. For first-trimester screening, the blood draw is usually done around the same time as the neck ultrasound. The sample goes to a laboratory, where the marker levels are measured and combined with your personal details to produce an estimated risk for each condition screened.
You can return to normal activities right away. Slight soreness or a small bruise where the needle went in usually fades quickly. Results are reported as a level of risk rather than a yes or no answer. A screen-positive, or higher-risk, result means the chance is higher than in the general population; it does not mean the baby has the condition. Abnormal results often turn out to reflect a pregnancy that is further along or less far along than thought, or twins, so the usual first step is an ultrasound to check the baby's age and look at development. A screen-negative, or lower-risk, result is reassuring but does not rule a condition out. After a higher-risk result, the care team or a genetic counselor can explain the options. These may include a detailed ultrasound of the brain, spine, heart and other organs, cell-free DNA screening, or a diagnostic test. Only diagnostic tests, amniocentesis (sampling the fluid around the baby) or chorionic villus sampling (CVS, sampling cells from the placenta), can confirm whether the fetus has a chromosomal condition. Some people decide not to pursue further testing, and that is also a valid choice.
The blood draw itself carries very little risk to you or the baby beyond minor pain or bruising. The main limitations are false-positive and false-negative results. A false positive can bring worry and lead to further tests for a baby who turns out not to have the condition, and a false negative can miss a condition that is present. Your care team can explain how often each happens with the specific test you are offered. Combined screening tends to be more accurate than a single test, but the final result may not be available until the second trimester. If a result leads to diagnostic testing, amniocentesis and CVS carry a very small risk of pregnancy loss, slightly higher with CVS. Weighing that risk against the value of a definite answer is part of the decision after screening.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Maternal Serum Screening Tests, what to expect, or ask the community a question.